Meridian Bioscience, Inc., a leading player in the life sciences industry, is headquartered in the United States. Founded in 1976, the company has established itself as a key provider of diagnostic products and life science reagents, primarily focusing on infectious disease testing and molecular diagnostics. With a strong presence in North America and Europe, Meridian Bioscience is renowned for its innovative solutions, including its proprietary immunoassay and molecular technologies. The company’s commitment to quality and accuracy has positioned it as a trusted partner in the healthcare sector. Notable achievements include significant advancements in rapid testing methodologies, which have enhanced patient care and diagnostic efficiency. Meridian Bioscience continues to drive progress in the industry, making it a pivotal entity in the realm of bioscience.
How does Meridian Bioscience, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Meridian Bioscience, Inc.'s score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Meridian Bioscience, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of SD Biosensor, Inc., which may influence its climate-related initiatives and reporting. While there are no documented reduction targets or specific climate pledges from Meridian Bioscience, the company is part of a broader industry context that increasingly prioritises sustainability and carbon footprint reduction. As a subsidiary, it may align with the climate commitments and strategies of its parent company, SD Biosensor, Inc., although specific details on these initiatives are not provided. In summary, Meridian Bioscience, Inc. is currently lacking in publicly available emissions data and defined climate commitments, reflecting a common challenge within the industry as companies strive to enhance transparency and accountability in their environmental impact.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Meridian Bioscience, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.